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Topoisomerase II (Top2) activity involves an intermediate in
which the topoisomerase is covalently bound to a DNA dou-
ble-strand break via a 5-phosphotyrosyl bond. Although these
intermediates are normally transient, they can be stabilized by
antitumor agents that act as Top2 “poisons,” resulting in the
induction of cytotoxic double-strand breaks, and they are im-
plicated in the formation of site-specific translocations that
are commonly associated with cancer. Recently, we revealed
that TRAF and TNF receptor-associated protein (TTRAP) is a
5-tyrosyl DNA phosphodiesterase (5-TDP) that can cleave
5-phosphotyrosyl bonds, and we denoted this protein tyrosyl
DNA phosphodiesterase-2 (TDP2). Here, we have generated
TDP2-deleted DT40 cells, and we show that TDP2 is the major
if not the only 5-TDP activity present in vertebrate cells. We
also show that TDP2-deleted DT40 cells are highly sensitive to
the anticancer Top2 poison, etoposide, but are not hypersensi-
tive to the Top1 poison camptothecin or the DNA-alkyating
agent methyl methanesulfonate. These data identify an impor-
tant mechanism for resistance to Top2-induced chromosome
breakage and raise the possibility that TDP2 is a significant
factor in cancer development and treatment.
Topoisomerases release torsional stress in DNA and decat-
enate chromosomes during mitosis (1, 2). A key intermediate
of topoisomerase activity is the cleavage complex, within
which the topoisomerase cleaves one or both strands of DNA
and becomes covalently linked to the 3 or 5 terminus of the
break via a phosphotyrosyl bond. The cleavage complex is
normally transient because the topoisomerase reseals the
break at the end of its catalytic cycle. However, cleavage com-
plexes are the targets of a class of antitumor agents that act as
topoisomerase “poisons,” prolonging the half-life of the
cleaved intermediate and resulting in the formation of poten-
tially cytotoxic DNA strand breaks (3). Whereas topoisomer-
ase I (Top1)4 poisons induce DNA breaks in which the topo-
isomerase is linked via a phosphotyrosyl bond to the 3
terminus of the break, topoisomerase II (Top2) poisons in-
duce DNA strand breaks in which the topoisomerase is linked
via a phosphotyrosyl bond to the 5 terminus. Top2-associ-
ated DNA breaks account not only for the clinical efficacy of
Top2 poisons as antitumor cytotoxic drugs, but are also im-
plicated in genome instability, chromosome translocations,
and carcinogenesis (4, 5). Recently, we identified a human
5-tyrosyl DNA phosphodiesterase (5-TDP) activity that can
cleave 5-phosphotyrosyl bonds and might thereby release
trapped topoisomerase from 5 termini (6). This enzyme, pre-
viously known as TTRAP, is a member of the metal-depen-
dent superfamily of phosphodiesterases and has been
implicated in NF-B signaling (7, 8), ETS1-mediated
transcriptional regulation (9), apoptotic regulation (10), and
left-right axis determination during development in zebrafish
(11). Based on its TDP activity we denoted TTRAP as tyrosyl
DNA phosphodiesterase 2 (TDP2) and speculated that this
enzyme might play an important role in the repair of Top2-
associated double strand breaks (DSBs) induced by Top2 poi-
sons (6). We now demonstrate using avian DT40 cells that
TDP2 is the primary if not the only 5-TDP activity in verte-
brate cells and that genetic deletion of TDP2 results in spe-
cific and severe sensitivity to Top2 poisons. These data iden-
tify TDP2 as a novel cellular component of the DNA repair
pathway(s) that protect cells from topoisomerase-induced
chromosomal breakage and suggest that TDP2 may be a use-
ful clinical target for inhibition during the chemotherapeutic
application of anticancer Top2 poisons.
EXPERIMENTAL PROCEDURES
5-Tyrosyl DNA Phosphodiesterase Activity—The 19-mer
and 20-mer DSB substrates were prepared as described
previously (6). Briefly, the 5-Y 18-bp (5-YTCCGTTGAAG-
CCTGCTTT-3) oligonucleotide was annealed with 19-bp
(5-GAAAGCAGGCTTCAACGGA-3) or 20-bp (5-AGAA-
AGCAGGCTTCAACGGA-3) oligonucleotides, respectively,
and the resulting 1-bp or 2-bp 5-overhang filled using Kle-
now DNA polymerase in the presence of [-32P]dCTP (for the
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19-mer) or both [-32P]dCTP and ddTTP (for the 20-mer).
Inclusion of the latter for the 20-mer inhibits degradation of
the substrate by nonspecific 3-nucleases present in whole cell
extract. For single-stranded and nicked duplex substrates, the
single-stranded 32P-labeled 5-Y 19-mer prepared as above
was gel-purified from denaturing gels and either employed
alone (single-stranded substrate) or annealed, along with the
21-bp oligonucleotide (5-GCGCAGCTAGCGGCGGAT-
GGC-3), to the 40-bp oligonucleotide (5-GAAAGCAGGC-
TTCAACGGAGCCATCCGCCGCTAGCTGCGC-3). Reac-
tions were carried out by incubating the indicated substrate
(50 nM) with whole cell protein extract (250 ng/ml) or the
indicated concentration of recombinant human His-TDP2/
TTRAP protein, which was expressed in Escherichia coli and
prepared as described previously (6), in 25 mM HEPES, pH
8.0, 130 mM KCl, 10 mM MgCl2, 1 mM DTT and in the pres-
ence or absence of orthovanadate, BSA, or phosphotyrosine-
BSA (Sigma) as indicated at 37 °C for 60 min. In reactions
containing cell extract 50 M competitor single-stranded oli-
gonucleotide (5-CTAACTTGAGCGAAACGGT-3) was also
included to further reduce nonspecific nucleolytic degrada-
tion of the duplex substrate. To examine whether the product
of hTDP2 activity was a ligatable 5 terminus, nicked duplex
substrate described above was incubated in ligation buffer
with hTDP2 and/or human DNA ligase III, which was
expressed in E. coli and purified as described previously (12,
13). All reactions were terminated by the addition of formam-
ide loading buffer and fractionated by denaturing PAGE;
images were analyzed by phosphorimaging.
Cell Cycle Analysis—Cells grown for the indicated time in
the presence or absence of 40 nM etoposide were fixed for
24 h in 70% ethanol at20 °C. Cells were then washed twice
in PBS and 3% BSA, resuspended in PBS containing 10 g/ml
propidium iodide and 100 g/ml RNase A, and analyzed us-
ing a FACS Canto device (Becton Dickinson).
Cell Culture and Transfection—Chicken DT40 B lym-
phoma cells were cultured in RPMI 1640 medium supple-
mented with 105 M -mercaptoethanol, penicillin, strepto-
mycin, 10% fetal calf serum (FCS), and 1% chicken serum
(Sigma) at 39 °C.
Generation of TDP2 Mutant DT40 Cells—To generate
TDP2 gene disruption constructs, TDP2 sequences were am-
plified by PCR from genomic DNA from DT40 cells (clone 18)
using the primer combinations 5-CCCAAGCTTGGAAAG-
TACTGTGCTCCGAGT-3 and 5-CGCGGATCCGCCCAT-
CAATGTTCCAAGTTAT-3 for the 5 arm, and 5-CGCGG-
ATCCGGATGAGCATGGACAATGAATA-3 and 5-CCG-
CTCGAGGCGCTGTAGGTAGAACAGAAGC-3 for the 3
arm. The amplified PCR products were cloned into the
pCR2.1-TOPO vector (Invitrogen) and confirmed by
sequencing. 2.5-kb HindIII/BamHI (left arm) and 4.4-kb
BamHI/XhoI (right arm) DNA fragments were then ligated
into pCR2.1-TOPO vector. A single drug-resistance gene
(Puro, HisD, or bsr) was then inserted into the BamHI site of
the pCR2.1 vector between the TDP2 targeting sequences. To
generate TDP2// cells, 2 107 cells were electroporated
(Bio-Rad) with 30 g of the relevant linearized (with XhoI)
TDP2 gene-disruption construct and drug-resistant colonies
selected by incubation in medium containing 0.5 g/ml puro-
mycin dihydrochloride (Sigma-Aldrich), 1.0 mg/ml D-histidi-
nol dihydrochloride (Sigma-Aldrich), or 25 g/ml blasticidine
S hydrochloride (Sigma-Aldrich), alone or in combination as
appropriate. To detect successful targeting of TDP2 alleles,
genomic DNA was isolated from multiple drug-resistant
clones, digested with XhoI and EcoRV, and subjected to
Southern blot analysis using a 0.8-kb probe (N-probe) ampli-
fied using the primers 5-TGAAGCAAAGCTGACAAGC-
TGC-3 and 5-CCAGTTAGCGGCAACATTTGAG-3.
Following three consecutive rounds of gene targeting with
constructs encoding resistance to Puro, HisD, and Bsr, respec-
tively, two TDP2// clones (clone 8 and clone 93) were
recovered. These clones were employed for phenotypic analy-
sis along with parental DT40 cells and a single TDP2//
clone (clone H13) in which only two of the three TDP2 alleles
were targeted.
Generation of hTDP2 and hTDP2 Catalytic Mutant Trans-
fected DT40 Cells—pcDNA3.1-HisC (Invitrogen) constructs
expressing wild-type human TDP2 and TDP2D262A were de-
scribed previously (note that TDP2 was previously denoted
TTRAP) (6). TDP2// DT40 cells were electroporated with
pcDNA3.1-HisC-TDP2, pcDNA3.1-HisC-TDP2 (D262A), or
pcDNA3.1-HisC empty vector. After selection in 1.5 mg/ml
G418 (Invitrogen) for 6 days, pooled populations of transfec-
tants were collected. For Western blotting, cell extracts were
prepared in radioimmune precipitation assay buffer (150 mM
NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS,
50 mM Tris-Cl, pH 8.0, 1 mM PMSF, and Complete protease
inhibitor mixture (Roche)), resolved by SDS-PAGE, and blot-
ted onto nitrocellulose membranes (GE Healthcare). Mem-
branes were blocked for 1 h in PBS-Tween 20 (PBST) con-
taining 5% nonfat dried milk (NFDM) and then incubated for
2 h with affinity-purified anti-TDP2 polyclonal antibody
(SY1340) (6) at a 1/200 dilution, in PBST plus 5% nonfat dried
milk. Membranes were rinsed in PBST and incubated in PBST
plus 5% nonfat dried milk containing horseradish peroxidase-
conjugated anti-rabbit IgG (DAKO), as appropriate, at a
1/3,000 dilution for 1 h at room temperature. Membranes
were then rinsed with PBST and antibody complexes detected
by enhanced chemiluminescence (GE Healthcare).
Clonogenic Survival Assays—To determine sensitivity, cells
were plated in 5 ml of medium containing 1.5% (by weight)
methylcellulose (Sigma-Aldrich) in 6-well plates at 50, 500,
and 5000 cells/well per treatment condition. Media also con-
tained the indicated concentration of methyl methanesulfon-
ate, camptothecin (CPT), or etoposide. In all experiments,
cells were incubated for 7–11 days and visible colonies
counted. The surviving fraction was calculated by dividing the
average number of visible colonies in treated wells by the av-
erage number of colonies in untreated wells.
RESULTS
TDP2 (also known as TTRAP) is the first human enzyme
with 5-TDP activity to be identified (6). To characterize this
enzyme further we examined its sensitivity to vanadate and its
DNA substrate specificity. The 5-TDP activity of histidine-
tagged TDP2 (His-TDP2) on oligonucleotide duplexes har-
TDP2 and Topoisomerase 2-induced DNADamage
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boring 5-phosphotyrosyl termini was inhibited by vanadate
(Fig. 1A). This is similar to the 3-TDP activity of TDP1 and
suggests the involvement of a phosphate transition state dur-
ing the 5-TDP reaction. To examine the specificity of His-
TDP2 for nucleic acid substrates we first examined whether
this activity was inhibited by BSA-tyrosine phosphate, a deriv-
ative of BSA containing a phosphotyrosine bond similar to
that present in the oligonucleotide 5-phosphotyrosyl sub-
FIGURE 1. The 5-TDP activity of His-TDP2 prefers DSBs and liberates ligatable 5 termini fromDNA 5-phosphotyrosine termini. A, purified recombi-
nant human His-TDP2 (100 nM) was incubated with 50 nM duplex substrate harboring a DSB with a 5-phosphotyrosine (P-Y) terminus (top) in the absence
or presence of the indicated concentrations of orthovanadate for 1 h at 37 °C and reaction products separated by denaturing PAGE and detected by autora-
diography. Right, quantification of the fraction (%) of total labeled oligonucleotide converted to 5-phosphate (19-mer) product is shown. Data are the aver-
age ( range) of two independent experiments. B, purified recombinant human His-TDP2 (100 nM) was incubated with duplex substrate as above in the
absence or presence of the indicated concentrations of BSA or phosphotyrosine-BSA. C, DNA substrates with a 5-phosphotyrosine terminus present in sin-
gle-stranded DNA (top), in a blunt-ended DNA duplex (middle), or in a nicked duplex (bottom), were incubated with the indicated concentrations of His-
TDP2 for 1 h at 37 °C and reaction products analyzed as above. Themiddle graph is the quantification (% of total labeled oligonucleotide converted to 5-P
19-mer product) of the above experiment, from three independent experiments mean (S.E.). Asterisk denotes statistically significant difference (p 0.05; t
test) between the indicated blunt-ended DNA duplex (ds-blunt) and single-stranded DNA (ss) data points. The bottom graph is a time course of TDP2 activity
(120 nM) on the blunt-ended DNA duplex (50 nM) from a single experiment. D, nicked DNA duplex harboring a 5-phosphotyrosine terminus (dotted box,
left) was incubated with () or without () 200 nM human His-TDP2 and 50 nM Lig3 and reaction products analyzed as described above. The predicted
reaction steps are depicted (left).
TDP2 and Topoisomerase 2-induced DNADamage
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strate. BSA-tyrosine phosphate failed to inhibit the activity of
His-TDP2, even if present at 60-fold higher concentrations
than the oligonucleotide 5-phosphotyrosyl substrate, sug-
gesting that His-TDP2 activity was specific for nucleic acid
substrates (Fig. 1B). His-TDP2 was active on a phosphotyrosyl
bond present at the 5 terminus of either a single-stranded
oligonucleotide, a DSB, or a single strand break (SSB), but was
most active on the DSB substrate (Fig. 1C). This is consistent
with a role for TDP2 in the repair of Top2-associated DSBs.
However, the activity of His-TDP2 on SSBs with 5-phospho-
tyrosyl termini may also be relevant because Top2 also in-
duces this type of break (4). We have suggested that the prod-
uct of TDP2 activity is a 5-phosphate terminus that is
competent for DNA ligation, based on the sensitivity of the
TDP2 product to calf intestinal phosphatase (6). This is an
important possibility because if true it would provide an er-
ror-free mechanism for repairing topoisomerase-associated
DNA breaks by simple DNA ligation. We therefore addressed
whether the termini created by TDP2 are ligatable, directly,
by employing a substrate that contained a 5-phosphotyrosyl
terminus within the context of a single-stranded nick. Indeed,
incubation of this substrate with His-TDP2 and DNA ligase,
but not with either His-TDP2 or DNA ligase alone, resulted in
conversion of the radiolabeled 19-mer containing the phos-
photyrosyl terminus into a radiolabeled 40-mer, confirming
that the His-TDP2 generates a ligatable 5-phosphate termi-
nus (Fig. 1D).
To examine directly the importance of TDP2 for the repair
and cellular resistance to Top2-associated DNA breaks we
disrupted each of the three TDP2 alleles in chicken DT40
cells, thereby creating a TDP2-deleted mutant cell line (sup-
plemental Fig. 1). The doubling time of TDP2// cells was
not significantly different from that of wild-type DT40 cells,
suggesting that cells proliferate at normal rates in the absence
of TDP2 (Fig. 2A). TDP2 is currently the only 5-TDP activity
identified in human cells. To address whether other such ac-
tivities might be present, we compared whole cell extracts
from TDP2//, TDP2//, and TDP2// cells for levels
of 5-TDP activity. Whereas whole cell extracts prepared from
wild-type TDP2// cells readily converted 5-phosphoty-
rosyl termini to 5-phosphate termini at a DSB end, whole cell
extracts from TDP2// cells failed to do so (Fig. 2, B and
C). We noted that cell extract from TDP2// cells exhib-
ited intermediate levels of 5-TDP activity, suggesting that a
single wild-type TDP2 allele is sufficient to provide detectable
levels of 5-TDP activity (Fig. 2B). Similar observations were
FIGURE 2. 5-Tyrosyl DNA phosphodiesterase activity in TDP2// cell extracts. A, growth curves of TDP2//, TDP2// (clone H13), and TDP2//
(clone 8) DT40 cells are shown. Data are the mean 1 S.D. of three independent experiments. B, duplex substrate harboring a DSB with a 5-phosphoty-
rosine terminus (upper) was incubated with whole cell extract from TDP2//, TDP2//, and TDP2// DT40 cells for 20, 40, and 60 min. Lower, the per-
centage of substrate converted to reaction product is shown (mean S.E. from three independent experiments). C, reactions conducted as in B employing
TDP2// or TDP2// cell extracts were extended to 120 min. D, duplex substrate harboring a SSB with a 5-phosphotyrosine terminus (middle) was in-
cubated with whole cell extract from TDP2//, TDP2//, and TDP2// DT40 cells for 20 min. The percentage of substrate converted to reaction prod-
uct is shown (right) (mean S.E. from three independent experiments). E, 5-TDP activity was analyzed as above in extracts from TDP2// cells trans-
fected with empty expression vector (Vector) or with expression vector encoding either wild-type human TDP2 (hTDP2) or human TDP2 with a mutated
catalytic domain (hTDP2D262A). hTDP2 and actin expression levels were analyzed by Western blotting with anti-hTDP2 and anti-actin antibodies, respectively
(bottom). All reaction products were analyzed by denaturing PAGE and phosphorimaging. The positions of substrate (YP-19) and repair product (P-19) are
indicated.
TDP2 and Topoisomerase 2-induced DNADamage
406 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 286•NUMBER 1•JANUARY 7, 2011
 at IN
STITU
TO
 D
E BIO
LO
G
IA
 FU
N
CIO
N
A
L Y
 G
EN
O
M
ICA
 CSIC on A
pril 14, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
observed for 5-phosphotyrosyl termini present at SSBs
(Fig. 2D). Stable expression of wild-type human TDP2 in
TDP2// cells (TDP2//hTDP2 cells) restored 5-TDP
activity, whereas stable expression of human TDP2D262A in
TDP2// cells (TDP2// hTDP2 D262A cells) harboring a
mutated active site did not, confirming that the absence of
5-TDP activity in TDP2// cells was the result of TDP2
deletion (Fig. 2E). Taken together, these data suggest that
TDP2 is the major if not the only 5-TDP activity present in
DT40 cell extracts.
Top2 poisons are an important class of antitumor agents
that exert their clinical efficacy by inducing Top2-associated
DSBs (14). Based on the 5-TDP activity of TDP2, we pro-
posed that this enzyme might be important for cellular resis-
tance to Top2 poisons (6). To test this hypothesis, we com-
pared the sensitivity of TDP2//, TDP2//, and
TDP2// cells to etoposide, a Top2 poison employed in the
treatment of lung, ovarian, and testicular cancer. Flow cytom-
etry revealed that cell cycle progression slowed in both
TDP2// and TDP2// cells within 24 h of addition of
40 nM etoposide to the culture medium (Fig. 3). However,
whereas the cell cycle profile in TDP2// cells returned to
near-normal within 48 h, a significant fraction of TDP2//
cells (24%) accumulated in a sub-G1 peak, indicative of cell
death (Fig. 3, bottom panels). To confirm the hypersensitivity
of TDP2// cells to etoposide we next employed clono-
genic survival assays. Strikingly, both of the two independent
TDP2// cell clones generated by gene targeting exhibited
high sensitivity to etoposide, with three-to-four log-cell kill
observed in TDP2// cells at etoposide concentrations that
were largely nontoxic to TDP2// or TDP2// cells (Fig.
4, A and B). Importantly, TDP2// hTDP2 cells expressing
human TDP2 exhibited levels of etoposide sensitivity
similar to TDP2// cells, confirming that the sensitivity of
TDP2// cells was due to loss of TDP2 protein (Fig. 4C).
Moreover, TDP2// hTDP2 D262A cells expressing catalyti-
cally impaired or inactive TDP2 were no more resistant to
etoposide than were untransfected TDP2// cells or
TDP2// cells transfected with empty vector, consistent
with a requirement for TDP2 phosphodiesterase activity for
cellular resistance to etoposide (Fig. 4C). In contrast to etopo-
side, TDP2// cells exhibited little or no hypersensitivity to
methyl methanesulfonate, a genotoxin that induces DNA base
damage that is repaired by the base excision repair pathway
(supplemental Fig. 2A). Similarly, TDP2// cells exhibited
little or no hypersensitivity to CPT a Top1 poison that in-
duces DNA strand breaks with Top1-associated DNA 3
termini (supplemental Fig. 2B). Together, these data demon-
strate that TDP2 is a novel component of the DNA damage-
response in vertebrate cells and that this enzyme is critical for
the survival of these cells to Top2-associated DNA strand
breaks.
DISCUSSION
We previously identified human TTRAP as a 5-tyrosyl
DNA phosphodiesterase and consequently denoted this pro-
tein TDP2 (6). Here, we have extended the biochemical analy-
sis of TDP2 and addressed, for the first time, the impact of
TDP2 deletion on vertebrate cells. The 5-TDP activity of
TDP2 was inhibited by vanadate, suggesting that, like TDP1,
cleavage of phosphotyrosyl bonds involves formation of a
phosphate transition state. The activity of TDP2 was not in-
hibited by the presence of excess BSA-tyrosine phosphate,
suggesting that TDP activity exhibits specificity for phospho-
tyrosyl bonds present in nucleic acid substrates. TDP2 exhib-
ited a small preference for 5-phosphotyrosyl termini at blunt
DSBs, compared with single strand 5 termini or internal 5
termini at SSBs, consistent with a role of TDP2 in the repair
Top2-induced DSBs in vivo. The activity of TDP2 on single
stranded termini may be physiologically relevant, however,
because the phosphotyrosyl terminus at a Top2 DSB is pres-
ent as a 4-bp 5 single stranded overhang. Similarly, the activ-
ity of TDP2 on 5-phosphotyrosyl SSBs may be physiologically
relevant because Top2 also induces this type of break, due
most likely to incomplete temporal coordination in the cleav-
age activity of the two Top2 subunits that comprise the active
homodimer (4). In addition, topoisomerase III also creates
FIGURE 3. Accumulation of TDP2// cells in sub-G1 and G2 following exposure to etoposide. Cell cycle profile of TDP2
// and TDP2// (clone 8)
DT40 cells that were cultured for 24 or 48 h in the presence or absence of 40 nM etoposide, as indicated, is shown. The accumulation of cells in G2/M or
sub-G1 in response to etoposide treatment is indicated by large and small arrowheads, respectively. The fraction of cells with sub-G1, G1, S phase, and G2
DNA content is expressed as a percent of the total cells in each sample and is tabulated.
TDP2 and Topoisomerase 2-induced DNADamage
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DNA breaks with 5-phosphotyrosyl termini and preferen-
tially does so in single stranded DNA (15, 16).
To examine the requirement for TDP2 for cellular response
to Top2-induced DNA damage we generated an avian DT40
cell line in which all three TDP2 alleles were disrupted. Nota-
bly, whereas robust 5-TDP activity was evident in wild-type
cell extracts we detected little or no residual activity in cell
extracts from TDP2-deleted cells. This suggests that TDP2 is
the primary, if not the only, 5-TDP activity in higher eu-
karyotes. In addition, deletion of TDP2 resulted in a high level
of hypersensitivity to the Top2 poison, etoposide, and expres-
sion of recombinant human TDP2 complemented this hyper-
sensitivity, consistent with TDP2 being a major mechanism
for the removal of trapped Top2 from DNA ends. Top2-in-
duced DSBs are composed of 4-bp complementary 5-over-
hangs in which the 5-overhangs harbor the phosphotyrosyl
termini. Consequently, because TDP2 can convert 5-phos-
photyrosyl termini into ligatable termini, TDP2 could provide
an error-free mechanism for repair of Top2 DSBs in which
the only additional DNA processing that is required is DNA
ligation. It is likely that TDP2 functions in conjunction with
components of the nonhomologous end-joining machinery,
with Ku and DNA ligase IV likely controlling events at the
DSBs before and/or after TDP2 activity. Consistent with this
idea, Lig4/ and Ku70/ DT40 cells also exhibit high levels
of sensitivity to etoposide (17).
In contrast to etoposide, little or no sensitivity was ob-
served in TDP2// DT40 cells to methyl methanesulfonate
or the Top1 poison CPT. The lack of sensitivity to methyl
methanesulfonate is consistent with this agent inducing DNA
breaks that possess 5-sugar phosphate (abasic) termini,
rather than 5-phosphotyrosyl termini. In contrast, CPT in-
duces DNA strand breaks in which Top1 is linked to 3 ter-
mini of DNA breaks via a phosphotyrosyl bond. Although
TDP2 possesses weak 3-TDP activity, it is likely that the pri-
mary source of such activity in cells is TDP1, providing a
likely explanation for the absence of sensitivity to CPT in
TDP2-deleted cells. However, we have shown previously that
TDP2 can complement the CPT sensitivity observed in bud-
ding yeast cells that lack both Tdp1 and Rad1/Rad10 nucle-
ase-dependent repair mechanisms for 3-phosphotyrosyl ter-
mini (6), raising the possibility that TDP2 may contribute to
the survival of vertebrate cells in the absence of TDP1 and/or
the Rad1/Rad10 homolog, ERCC1/XPF.
In summary, we describe here the first characterization of a
TDP2-deleted cell line and demonstrate that TDP2 is the pri-
mary if not the only source of 5-tyrosyl DNA phosphodies-
terase activity in vertebrate cell extracts. Moreover, we show
that genetic deletion of TDP2 results in specific and high sen-
sitivity to the Top2 poison and anticancer agent, etoposide,
identifying TDP2 as a critical new component of the cellular
defense against Top2-induced DNA damage. Top2 damage
not only accounts for the clinical efficacy of Top2 poisons, an
important and commonly used class of anticancer agents, but
also accounts for some of the commonest site-specific trans-
locations observed in human cancer (4, 5). Consequently,
FIGURE 4. Cellular hypersensitivity of TDP2// cells to the Top2 poison, etoposide. A, clonogenic survival of TDP2//, TDP2//, and TDP2//
(clone 8) cells cultured in the indicated concentrations of etoposide. B, clonogenic survival of TDP2// and TDP2// (clone 93) cells cultured as above.
C, clonogenic survival of TDP2// cells, TDP2// cells (clone 8), and pooled populations of TDP2// (clone 8) transfectants harboring empty expres-
sion vector (vector) or expression vector encoding either wild-type human TDP2 (TDP2) or TDP2 with a mutated catalytic domain (TDP2 D262A). Data are the
mean S.E. of three independent experiments. Where not visible, error bars are smaller than the symbols.
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TDP2 activity may thus impact significantly both on the de-
velopment and subsequent treatment of cancer, and inhibi-
tors of this novel enzyme may have clinical utility.
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